INHIBITION OF FLT3 SIGNALING BOTH IN VITRO AND IN VIVO BY AC220, A SECOND GENERATION POTENT AND SELECTIVE FLT3 INHIBITOR

被引：0
|
作者：
Armstrong, R. [1 ]
Gunawardane, R. [1 ]
Rooks, A. [1 ]
Dao, A. [1 ]
Ricono, J. [1 ]
Brigham, D. [1 ]
Zarrinkar, P. [1 ]
Belli, B. [1 ]
Wierenga, W. [1 ]
机构：
[1] Ambit Biosci, San Diego, CA USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [31] Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells
    Tomohiro Hirade
    Mariko Abe
    Chie Onishi
    Takeshi Taketani
    Seiji Yamaguchi
    Seiji Fukuda
    International Journal of Hematology, 2016, 103 : 95 - 106
  • [32] Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells
    Hirade, Tomohiro
    Abe, Mariko
    Onishi, Chie
    Taketani, Takeshi
    Yamaguchi, Seiji
    Fukuda, Seiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (01) : 95 - 106
  • [33] AC220, a Potent and Specific FLT3 Inhibitor, Enhances the Cytotoxic Effects of Chemotherapeutic Agents in Cell Culture and in Mouse Tumor Xenografts.
    Belli, Barbara A.
    Dao, Alan
    Bhagwat, Shripad
    Wierenga, Wendell
    Armstrong, Robert C.
    BLOOD, 2009, 114 (22) : 810 - 810
  • [34] Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD-positive AML
    Cortes, Jorge
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [35] Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells
    Abe, Mariko
    Pelus, Louis M.
    Singh, Pratibha
    Hirade, Tomohiro
    Onishi, Chie
    Purevsuren, Jamiyan
    Taketani, Takeshi
    Yamaguchi, Seiji
    Fukuda, Seiji
    PLOS ONE, 2016, 11 (07):
  • [36] Signaling adaptation to FLT3 inhibition in FLT3/ITD leukemia results in a reactivation of ERK signaling that can be abrogated with MEK inhibition
    Bruner, J. Kyle
    Ma, Hayley
    Pratilas, Christine
    Small, Donald
    CANCER RESEARCH, 2016, 76
  • [37] Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations
    Wang, Zhijie
    Cai, Jiongheng
    Ren, Jiwei
    Chen, Yun
    Wu, Yingli
    Cheng, Jie
    Jia, Kun
    Huang, Fei
    Cheng, Zitian
    Sheng, Tiancheng
    Song, Shiyu
    Heng, Hao
    Zhu, Yifan
    Tang, Weifang
    Li, Hongmei
    Lu, Tao
    Chen, Yadong
    Lu, Shuai
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14664 - 14701
  • [38] Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736
    Moore, Andrew S.
    Faisal, Amir
    Bavetsias, Vassilios
    de Castro, David Gonzalez
    Sun, Chongbo
    Atrash, Butrus
    Valenti, Melanie
    Brandon, Alexis de Haven
    Avery, Sian
    Pearson, Andrew D. J.
    Workman, Paul
    Blagg, Julian
    Raynaud, Florence I.
    Eccles, Suzanne A.
    Linardopoulos, Spiros
    BLOOD, 2011, 118 (21) : 1490 - 1490
  • [39] Generation of dendritic cells in vivo with FLT3 ligand
    Caron, D
    Lebsack, ME
    Maraskovsky, E
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 400 - 400
  • [40] Generation of dendritic cells in vivo with Flt3 ligand
    Caron, D
    Roux, E
    Teepe, M
    McKenna, H
    Maraskovsky, E
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
12345